• Discussion on the POINT trial (with Marc Fisher and Greg Albers)

  • 2021/03/02
  • 再生時間： 18 分
  • ポッドキャスト

Discussion on the POINT trial (with Marc Fisher and Greg Albers)

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • Professor Marc Fisher and Dr Greg Albers discuss the POINT trial, also commenting on when to consider ticagrelor versus clopidogrel.

    This programme is made possible thanks to an independent educational grant from AstraZeneca.

    Find more information at https://ime.springerhealthcare.com/programs/emerging-dual-anti-platelet-therapy-strategies-for-neurologists-in-secondary-stroke-prevention/
    続きを読む 一部表示

あらすじ・解説

Professor Marc Fisher and Dr Greg Albers discuss the POINT trial, also commenting on when to consider ticagrelor versus clopidogrel.

This programme is made possible thanks to an independent educational grant from AstraZeneca.

Find more information at https://ime.springerhealthcare.com/programs/emerging-dual-anti-platelet-therapy-strategies-for-neurologists-in-secondary-stroke-prevention/
続きを読む 一部表示

Discussion on the POINT trial (with Marc Fisher and Greg Albers)に寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。